re this comment: "PRR is the only company in the world doing late stage ovarian cancer trials."
I think this should be restates as: "PRR is the only company in teh world doing late stage ovarian cancer VACCINE trials".
there are any number of late stage trials that involve different therapeutic technologies. Many of these have been discussed on hotcopper at some time or other.
Other corrections would include:
- the 2018 patent applies only to Europe, not USA
- Martin indicated that he had more than enough funding for Phase IIb, but there was no mention of Phase III (which will presumably cost $100 million - it does for everyone else, and I don't know why PRR would be any different)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
-0.005(1.92%) |
Mkt cap ! $376.0M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 27.5¢ | 25.5¢ | $1.276M | 4.866M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 22343 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 193000 | 3 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |